8月11日周一盘前，大麻股Cronos Group Inc.（CRON）股价大涨20.43%，引发市场广泛关注。此轮涨势主要受到一则关于美国前总统特朗普可能调整大麻政策的消息推动。
据《华盛顿邮报》报道，特朗普在本月初的一场筹款晚宴上表示，他有意将大麻重新归类为危险性较低的药物。这一消息引发了投资者对大麻行业前景的乐观预期，导致包括Cronos在内的多家大麻公司股价集体上涨。
如果这一政策变化最终实现，将大大简化大麻的买卖流程，为这个价值数十亿美元的产业带来更多盈利机会。自1971年美国《联邦管制物质法案》实施以来，大麻一直被列为一级管制药物。重新分类将有可能为Cronos等大麻公司开辟新的市场，并有望吸引更多投资，这也解释了为什么投资者对这一消息反应如此强烈。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.